BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Ouali S, Click B, Holubar SD, Rieder F. Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease. United European Gastroenterol J 2020;8:263-70. [PMID: 32213020 DOI: 10.1177/2050640620901960] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Barreiro-de Acosta M, Fernández-Clotet A, Mesonero F, García-Alonso FJ, Casanova MJ, Fernández-de la Varga M, Cañete F, de Castro L, Gutiérrez A, Sicilia B, Cano V, Merino O, de Francisco R, González-Partida I, Surís G, Torrealba L, Ferreiro-Iglesias R, Castro B, Márquez L, Sobrino A, Elorza A, Calvet X, Varela P, Vicente R, Bujanda L, Lario L, Manceñido N, García-Sepulcre MF, Iglesias E, Rodríguez C, Piqueras M, Ferrer Rosique JÁ, Lucendo AJ, Benítez O, García M, Olivares D, González-Muñoza C, López-Cauce B, Morales Alvarado VJ, Spicakova K, Brotons A, Bermejo F, Almela P, Ispízua N, Gilabert P, Tardillo C, Muñoz F, Navarro P, Madrigal Domínguez RE, Sendra P, Hinojosa E, Sáinz E, Martín-Arranz MD, Carpio D, Ricart E, Caballol B, Núñez L, Barrio J, Gisbert JP, Iborra M, Calafat M, Hernández V, Muñoz Pérez R, Cabriada JL, Domènech E, Rodríguez-Lago I; BIOSCOPE study group from the ENEIDA registry. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU. Am J Gastroenterol 2023. [PMID: 36516073 DOI: 10.14309/ajg.0000000000002152] [Reference Citation Analysis]
2 Liu Z, Sun J, Yang H, Lin H, Li M, Liu Z, Kurban M, Gao X, Zhang N, Guo Q. Long-term Efficacy of Endoscopic Balloon Dilatation in Patients with Small bowel Strictures Secondary to Crohn’s Disease.. [DOI: 10.21203/rs.3.rs-2441897/v1] [Reference Citation Analysis]
3 Dovrolis N, Filidou E, Tarapatzi G, Kokkotis G, Spathakis M, Kandilogiannakis L, Drygiannakis I, Valatas V, Arvanitidis K, Karakasiliotis I, Vradelis S, Manolopoulos VG, Paspaliaris V, Bamias G, Kolios G. Co-expression of fibrotic genes in inflammatory bowel disease; A localized event? Front Immunol 2022;13:1058237. [PMID: 36632136 DOI: 10.3389/fimmu.2022.1058237] [Reference Citation Analysis]
4 El Ouali S, Baker ME, Lyu R, Fletcher JG, Bruining DH, Holubar SD, Click B, Qazi T, Cohen BL, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease. United European Gastroenterol J 2022;10:958-72. [PMID: 36479841 DOI: 10.1002/ueg2.12314] [Reference Citation Analysis]
5 Tavares de Sousa H, Carneiro F. Understanding progression of strictures in ileal Crohn's disease-The importance of setting methodological standards. United European Gastroenterol J 2022;10:915-6. [PMID: 36251489 DOI: 10.1002/ueg2.12327] [Reference Citation Analysis]
6 Sivasailam B, Lane BF, Cross RK. Endoscopic Balloon Dilation of Strictures. Gastrointestinal Endoscopy Clinics of North America 2022. [DOI: 10.1016/j.giec.2022.04.006] [Reference Citation Analysis]
7 Martins CDA, Garcia KS, Queiroz NSF. Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases. Front Med 2022;9. [DOI: 10.3389/fmed.2022.864888] [Reference Citation Analysis]
8 Holzer K, Denzer U. Ileus – Update 2022. Gastroenterologie up2date 2022;18:51-67. [DOI: 10.1055/a-1355-0474] [Reference Citation Analysis]
9 Nones RB, Fleshner PR, Queiroz NSF, Cheifetz AS, Spinelli A, Danese S, Peyrin-Biroulet L, Papamichael K, Kotze PG. Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical Patient. J Clin Med 2021;10:5642. [PMID: 34884344 DOI: 10.3390/jcm10235642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ślósarz D, Poniewierka E, Neubauer K, Kempiński R. Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease-Systematic Review. J Clin Med 2021;10:4044. [PMID: 34575156 DOI: 10.3390/jcm10184044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Skamnelos A, Lazaridis N, Vlachou E, Koukias N, Apostolopoulos P, Murino A, Christodoulou D, Despott EJ. The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021. Ann Gastroenterol 2021;34:599-611. [PMID: 34475730 DOI: 10.20524/aog.2021.0652] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Abdulla M, Chew TS. Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease. Curr Opin Gastroenterol 2021;37:275-83. [PMID: 33769380 DOI: 10.1097/MOG.0000000000000729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Sleiman J, El Ouali S, Qazi T, Cohen B, Steele SR, Baker ME, Rieder F. Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges. Expert Rev Gastroenterol Hepatol 2021;15:401-11. [PMID: 33225766 DOI: 10.1080/17474124.2021.1854732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]